𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia

✍ Scribed by Liu, C; Kawedia, J D; Cheng, C; Pei, D; Fernandez, C A; Cai, X; Crews, K R; Kaste, S C; Panetta, J C; Bowman, W P; Jeha, S; Sandlund, J T; Evans, W E; Pui, C-H; Relling, M V

Book ID
119980295
Publisher
Nature Publishing Group
Year
2012
Tongue
English
Weight
303 KB
Volume
26
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical utility and implications of asp
Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia
✍ Liu, C; Kawedia, J D; Cheng, C; Pei, D; Fernandez, C A; Cai, X; Crews, K R; Kast πŸ“‚ Article πŸ“… 2012 πŸ› Nature Publishing Group 🌐 English βš– 303 KB

Hypersensitivity to asparaginase is common, but the differential diagnosis can be challenging and the diagnostic utility of antibody tests is unclear. We studied allergic reactions and serum antibodies to E. coli asparaginase (Elspar) in 410 children treated on St. Jude Total XV protocol for acute l

Antibody against poly(ethylene glycol) a
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
✍ Jonathan K. Armstrong; Georg Hempel; Susanne Koling; Linda S. Chan; Timothy Fish πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 191 KB

## Abstract ## BACKGROUND. Rapid clearance of poly(ethylene glycol)‐asparaginase (PEG‐ASNase) has been reported for up to one‐third of patients treated for acute lymphoblastic leukemia (ALL), potentially rendering their treatment ineffective. A 25% occurrence of an antibody against PEG (anti‐PEG)

Methotrexate and asparaginase combinatio
Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia of childhood
✍ Jeffrey S. Lobel; Richard T. O'Brien; Sue McIntosh; Gregg T. Aspnes; Robert L. C πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 526 KB

Two groups of children with refractory acute lymphoblastic leukemia were treated with a regimen of methotrexate (MTX) and asparaginase (Asn'ase) based on studies of the effect of MTX in vitro on human lymphoblasts exposed to Asn'ase. Induction therapy in 12 children produced 4 complete remissions, 3